Alvotech
ALVO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $157.4M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVOW
Q1 2026 vs. Q4 2025
How the institutions holding Alvotech changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 49 | 1 | 57 | +9 |
| Shares | 15.6M | 4.49M | 17.0M | +5.93M (+53.5%) |
| Value | $78.1M | $22.6M | $57.3M | +$1.79M (+3.2%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Alvotech at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 3,410,447 | $11.8M | 0.00% |
| Vanguard Fiduciary Trust Co | 974,228 | $3.38M | 0.00% |
| Vanguard Asset Management, Ltd | 151,935 | $527.2K | 0.00% |
| Savant Capital, LLC | 77,818 | $266.9K | 0.00% |
| Jump Financial, LLC | 46,442 | $159.3K | 0.00% |
| ExodusPoint Capital Management, LP | 32,159 | $110.3K | 0.00% |
| Axq Capital, LP | 24,920 | $85.5K | 0.01% |
| Teucrium Investment Advisors, LLC | 17,845 | $61.2K | 0.05% |
| Commonwealth Equity Services, LLC | 17,276 | $59.3K | 0.00% |
| Quadrature Capital Ltd | 16,412 | $56.3K | 0.00% |
| Wells Fargo & Company | 5,000 | $17.1K | 0.00% |
| Jones Financial Companies LLLP | 3,370 | $10.5K | 0.00% |
| Wolverine Asset Management LLC | 1,284 | $4.40K | 0.00% |
| EverSource Wealth Advisors, LLC | 240 | $824 | 0.00% |
| Stone House Investment Management, LLC | 94 | $322 | 0.00% |
| National Bank of Canada | 35 | $120 | 0.00% |
Sold out (7)
Institutions that held Alvotech at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| PointState Capital LP | 1,049,039 | $5.38M |
| Jane Street Group, LLC | 92,314 | $473.6K |
| Bank of America Corp | 35,503 | $182.1K |
| Amundi | 19,416 | $99.6K |
| Point72 Asset Management, L.P. | 14,840 | $76.1K |
| Daiwa Securities Group Inc. | 1,030 | $5.00K |
| Allworth Financial LP | 150 | $770 |
Not filed for Q1 2026 yet (1)
Institutions that held Alvotech at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 4,490,099 | $22.6M |